AgomAb Therapeutics NV (AGMB) stock
AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.62−0.20 (-3.44%)
Close on Nov 19, 2026Market cap $140.50KP/E –Yield –
AgomAb Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 1M, up 0.0% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | 0.0% |
| FY2024 | Dec 31, 2024 | 1M | 0.0% |
| FY2023 | Dec 31, 2023 | 1M | – |
See a number that looks wrong?